Tag: Business

  • Pajson Agro Reports Robust 37% Revenue Growth to Rs 256.92 Crore in FY26

    Pajson Agro Reports Robust 37% Revenue Growth to Rs 256.92 Crore in FY26

    New Delhi [India], May 7: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012)), a renowned integrated cashew processing and distribution company, announced its audited financial results for H2 FY26.

    H2 FY26 Standalone Key Financial Highlights

    • Total Income of ₹138.54 Cr, YoY growth of 37.38%
    • EBITDA of ₹16.76 Cr, YoY growth of 18.68%
    • Net Profit of ₹10.57 Cr, YoY growth of 9.04%

    FY26 Standalone Key Financial Highlights

    • Total Income of ₹256.92 Cr, YoY growth of 37.18%
    • EBITDA of ₹37.82 Cr, YoY growth of 24.99%
    • Net Profit of ₹24.78 Cr, YoY growth of 21.45%

    Segment-wise Revenue Mix

    • Disributors: 65.21%
    • Institutions: 33.96%
    • Misc Revenue: 0.83%

    Key Revenue Contributing States

    • Delhi: 24.76%
    • Maharashtra: 13.40%
    • Rajasthan: 12.94%
    • Others: 48.90%

    Commenting on the performance, Mr. Aayush Jain, Promoter, Chairman & Managing Director, said:

    “FY26 has been a defining and milestone year for Pajson Agro. Alongside delivering strong financial growth, we successfully achieved our BSE SME listing in December 2025, marking an important step in our long-term journey of building a scalable and integrated cashew processing platform.

    Our performance reflects the strength of our institution-led business model, deep sourcing relationships, efficient processing capabilities, and expanding customer network across India. Demand for quality cashew products continues to remain strong across food brands, wholesalers, ingredient manufacturers, snack manufacturers, bakery manufacturers, sweet manufacturers, food processors, retailers, and HoReCa players, giving us confidence in the long-term growth potential of the industry.

    Over the last few years, we have focused on creating a strong operational foundation with disciplined execution, quality consistency and efficient procurement. As we move ahead, our upcoming capacity expansion from 18,000 MTPA to 55,000 MT will significantly strengthen our ability to serve larger customers, improve scale efficiencies and unlock the next phase of growth.

    We believe the cashew industry presents a large and underpenetrated opportunity, both in India and globally, and Pajson Agro is well positioned to emerge as a meaningful player in this evolving value chain.”

    Commenting on the growth outlook, Mr. Pulkit Jain, Promoter & Non-Executive Director, added:

    “Our focus has always been on building Pajson Agro with a long-term and value-driven approach. FY26 reflects the outcome of consistent efforts across sourcing, processing, distribution and customer expansion.

    The company today operates with a diversified institutional customer base; a growing distributor network and a near-zero waste processing model that enables better value realization across the cashew value chain. We are also seeing encouraging traction for our consumer brand ‘Royal Mewa’, which we believe can become an important growth driver over the coming years.

    India continues to remain one of the world’s largest cashew consumption markets, while global demand for healthy snacking and food ingredients is steadily increasing. With our integrated business model, scalable infrastructure and strong market relationships, we are optimistic about the opportunities ahead.

    The successful listing during the year has further strengthened our visibility and growth platform, and we remain committed towards building a larger, stronger and more trusted agri-processing enterprise in the years to come.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Digikore Studios Delivers Blockbuster FY26 Results, Revenue Surges 83.1% to Rs 66.02 Crore, PAT at Rs 12.64 Crore, Net Worth Rises 37.1% to Rs 47.68 Crore

    Digikore Studios Delivers Blockbuster FY26 Results, Revenue Surges 83.1% to Rs 66.02 Crore, PAT at Rs 12.64 Crore, Net Worth Rises 37.1% to Rs 47.68 Crore

    New Delhi [India], May 7: Digikore Studios Limited (NSE: DIGIKORE), a leading technology-driven Visual Effects studio, today announced its audited consolidated financial results for FY2025–26, marking a strong turnaround year for the Company. 

    Backed by the disciplined execution framework of Project Abhimanyu, Digikore delivered sharp growth in revenue, a return to strong profitability, significant margin expansion, and a meaningful strengthening of its balance sheet—positioning the Company on a stronger footing for the next phase of growth.

    Key FY2025–26 Financial Highlights

    Growth & Profitability

    Revenue from Operations: ₹66.02 crore, up 83.1% YoY 

    • Total Revenue: ₹70.86 crore, up 91.5% YoY 
    • Profit Before Tax: ₹15.37 crore versus loss of ₹9.61 crore in FY2024–25 
    • Profit After Tax: ₹12.64 crore versus loss of ₹7.20 crore in FY2024–25 
    • PAT Margin: Approximately 17.8% versus negative 19.5% in FY2024–25 
    • Earnings Per Share: ₹9.98 versus negative ₹11.37 in FY2024–25 

    Efficiency Indicators

    • Employee Benefits Expense: Down 13.4% YoY despite strong revenue growth 
    • Total Expenses: Up only 19.0% against 91.5% growth in Total Revenue 

    Strengthened Financial Position

    • Digikore’s financial position improved materially during the year, with Net Worth increasing 37.1% to ₹47.68 crore as of 31 March 2026, from ₹34.77 crore a year earlier.

    Project Abhimanyu Driving Turnaround Execution

    The Company said FY2025–26 performance reflects the early impact of Project Abhimanyu, its structured 12–18 month strategic program focused on strengthening financial resilience, improving cashflow quality, enhancing execution discipline, increasing financial flexibility, and rebuilding stakeholder confidence.

    The program was launched to create a stronger and more scalable platform for long-term growth as global VFX demand normalizes and international opportunities improve.

    Strong Operating Leverage Supports Profitability Recovery

    A key highlight of the year was Digikore’s strong operating leverage, with Total Revenue growing 91.5% while Total Expenses increased only 19.0%, driving a sharp improvement in profitability.

    Further, Employee Benefits Expense declined 13.4% year-on-year despite the strong increase in business volumes, reflecting tighter execution, improved productivity, and stronger operating discipline.

    The Company believes these outcomes validate the strategic direction of Project Abhimanyu, which was designed not as a short-term intervention, but as a phased, governance-led effort to strengthen the business across capital structure, execution readiness, and long-term value creation.

    Positioned to Capture Global VFX Recovery and Drive Sustainable Growth

    Digikore stated that FY2025–26 also benefited from improving global demand conditions as the VFX industry continued to recover from the impact of the Hollywood strikes. Under Project Abhimanyu, the Company sharpened its business development focus, improved execution quality, and enhanced readiness to pursue larger international opportunities. Going forward, the Company remains committed to executing the program in a disciplined and transparent manner, with a clear focus on strengthening financial resilience, capturing global VFX upcycle opportunities, and driving sustainable long-term stakeholder value creation.

    Commenting on the Performance, Mr. Abhishek More, Founder & CEO, Digikore Studios Limited, said: “FY25–26 has been a strong turnaround year for Digikore Studios. Under Project Abhimanyu, we remained sharply focused on disciplined execution, stronger financial management, and building a more resilient and scalable business. The results are visible in our audited numbers — strong revenue growth, return to profitability, improved margins, and a stronger balance sheet. We believe this performance marks an important inflection point for Digikore. As the global VFX cycle improves and our business development efforts continue to gain traction, we believe the Company is now better positioned to pursue larger opportunities, scale with greater confidence, and create long-term value for shareholders.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Akash Singh Thakur on Modern Fraud, Corporate Ethics & the Growing Importance of Investigative Awareness in India

    Akash Singh Thakur on Modern Fraud, Corporate Ethics & the Growing Importance of Investigative Awareness in India

    With over 13+ years of experience across forensic analysis, corporate investigations, vigilance, and risk review, Akash Singh Thakur shares his perspective on modern investigative systems, ethical business practices, and the importance of trust-driven ecosystems.

    Mumbai (Maharashtra) [India], May 6: In today’s rapidly evolving environment, concerns related to financial fraud, digital manipulation, misinformation, document forgery, corporate misconduct, and trust deficit are becoming increasingly significant across both personal and professional spaces. As technology and business systems continue to evolve, the importance of forensic awareness, ethical processes, investigative discipline, and structured verification mechanisms has also grown considerably.

    According to forensic and investigation professional Akash Singh Thakur, the role of modern investigative systems today extends far beyond traditional crime-related matters and now plays an important role in areas such as corporate governance, compliance, risk management, transparency, operational integrity, and accountability.

    “With changing times, the nature of irregularities and manipulation is also evolving. Today, awareness, verification, and responsible systems are becoming equally important for organizations as well as individuals,” says A.S. Thakur.

    With over 13 years of professional experience across corporate, legal, and high-sensitivity investigative environments, Akash Singh Thakur has worked across multiple sectors involving fraud review, vigilance operations, investigative analysis, forensic consulting, compliance assessment, and evidence-based review processes. His professional journey includes associations with organizations such as ICICI Lombard, Welspun Group, Care Health Insurance, Axis Bank, Onsitego, and multiple independent forensic and investigative assignments across India.

    Professionally associated since 2012 with Vijayshree Ramesh Madan, widely regarded as the Founding Father of Private Investigation in India and recipient of the prestigious Lifetime Achievement Award by the Hon’ble President of India (2009), A.S. Thakur has developed his professional foundation through practical exposure to forensic methodologies, investigative procedures, court-related forensic reviews, fraud analysis, and evidence-oriented assignments.

    Akash Singh Thakur - PNN

    Over the years, his work exposure has included assignments connected with fraud investigations, disputed documents, internal reviews, risk analysis, compliance processes, vigilance operations, and investigative consulting involving both corporate and legal environments. Several assignments also involved confidential and high-sensitivity matters requiring analytical review, structured observation, and evidence-based assessment.

    According to A.S. Thakur, one of the key challenges modern society faces today is the increasing sophistication of manipulation — whether in digital communication, financial systems, documentation, organizational structures, or public perception. In his view, investigation today is not only about identifying irregularities but also about strengthening systems, improving awareness, and encouraging accountability-driven practices.

    “Professional investigation is not simply about reacting to situations. It is equally about building preventive systems, encouraging transparency, and helping organizations strengthen ethical and operational discipline,” he explains.

    His professional exposure further includes investigative support in criminal and civil matter environments, document examination, fraud risk reviews, insurance investigations, and court-related forensic assignments.

    Apart from the investigative and forensic domain, Akash Singh Thakur is also associated as Co-founder of HALDIVA INDIA “A Golden Touch to a Healthy Life” — a wellness and natural products brand focused on purity, transparency, and responsible business practices. Interestingly, he believes that the principles valued in forensic and investigative professions — authenticity, accountability, verification, and operational integrity — are equally important in building modern consumer-focused businesses.

    “The foundation of every strong system, whether investigative or entrepreneurial, ultimately comes down to trust,” A.S. Thakur shares.

    Akash Singh Thakur - PNN

    Recognised within professional circles through acknowledgements such as the Kautalya Award and Chanakya Award in the investigative fraternity, A.S. Thakur continues to remain actively engaged with investigative awareness, forensic consulting, compliance-oriented assignments, and responsible business initiatives.

    His long-term vision remains centred on continuous learning, professional discipline, ethical growth, and contributing meaningfully towards more transparent, accountable, and awareness-driven systems in both society and business.

    As discussions around ethics, digital trust, compliance, operational integrity, and responsible entrepreneurship continue to evolve in India, professionals like Akash Singh Thakur represent a growing category of specialists quietly working at the intersection of forensic science, investigative analysis, strategic risk understanding, and ethical business leadership — contributing towards stronger systems built on transparency, discipline, and professional responsibility.

    For more information, please contact:
    Akash Singh Thakur
    Senior Forensic Expert | Consultant
    Co-founder – HALDIVA INDIA
    India

  • 5 Reasons Why U.S. Cranberries Belong in Indian Diets

    5 Reasons Why U.S. Cranberries Belong in Indian Diets

    New Delhi [India], May 6: As Indian consumers grow more conscious about what they eat, there’s a clear shift toward foods that offer both nutrition and versatility. Superfoods are no longer niche—they’re steadily finding a place in everyday kitchens. Among these, U.S. cranberries are gaining attention for their balance of health benefits, tangy flavor, and ease of use across different cuisines.

    1. Boosts Immunity Naturally

    U.S. cranberries are a rich source of vitamin C and antioxidants, both essential for building resistance against infections, especially during seasonal changes. A few dried cranberries daily can help keep your immune system strong—naturally.

    1. Blends Beautifully with Indian Cuisine

    Cranberries pair surprisingly well with Indian flavors. Use dried cranberries in poha, pulao, or laddoos, or add cranberry juice to chutneys and marinades. The tartness balances the spices and enhances overall taste.

    1.  Supports Women’s Health

    Cranberries are especially well-known for promoting urinary tract health, making them an important addition to women’s wellness routines. Regular intake of cranberry juice or dried cranberries may help prevent common infections naturally.

    1. Smart Snacking Made Nutritious

    With good cholesterol or added fats, dried cranberries are a nutritious addition to your daily routine. Toss them into trail mixes, blend them into smoothies, or enjoy them as a convenient on-the-go snack.

    1. Available Year-Round in Convenient Forms

    US Cranberries are accessible in India in multiple convenient forms—dried, frozen, powdered, and as juice or extract. This makes it easy to incorporate them into daily meals, whether you’re cooking, baking, or blending or just snacking.

    As Indian consumers continue to explore superfoods that support holistic health, U.S. cranberries offer a unique combination of nutrition, taste, and global quality assurance. Whether you’re a home chef, a parent, or a fitness enthusiast, cranberries bring a world of wellness to every plate.

    US cranberries are easily available in India now with dry fruits stores and e-commerce platforms.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Beyond Kibble: A Quiet Bet on Clinical Pet Nutrition Is Reshaping India’s D2C Wellness Map

    Beyond Kibble: A Quiet Bet on Clinical Pet Nutrition Is Reshaping India’s D2C Wellness Map

    How Whole Woofs is closing the import gap that the country’s $7-billion pet boom forgot to fix.

    New Delhi [India], May 6: Walk into a premium pet store in Mumbai, Bengaluru, or Delhi and a familiar scene plays out. A young pet parent, phone in hand, a senior Labrador’s joint problem on her mind, turns over a bottle, squints at the colony-forming-unit count, and frowns. The dosage is too low. The strain count is thin. The brand she actually wants sits on a US storefront, three weeks and a customs lottery away, marked up hard by the time it reaches Andheri.

    This has been the unglamorous bottleneck of India’s pet wellness boom. The country’s pet care market is marching toward $7 billion. FMCG conglomerates and pharma majors are crowding into food and feed. Yet high-potency therapeutic nutraceuticals have remained under-served, leaving pet parents to choose between underdosed local multivitamins and an “import trap” of expensive, slow, counterfeit-prone US SKUs. Into that gap, in September 2025, stepped Whole Woofs.

    Whole Woofs’ brief is unusually narrow. Not a food brand, not a wellness lifestyle play but a clinical pet nutrition company that sells clean highest quality dog supplements, full stop.

    The thesis is import substitution at the formulation level: match American clinical-brand potency, manufacture in India to GMP, HACCP, ISO 9001 standards, and price for Tier-1 pet parents done pretending a multivitamin biscuit counts as preventive care.

    “We were buying high-potency probiotics for our own dog and shipping them back to family pets in India,” says Dr. Ketan Bacchuwar, Founder. “The science and manufacturing both exist in India today. Nobody had put them together with the dosing discipline of a pharmaceutical product.”

    The label does the talking. The Pre & Probiotic packs 9.6 billion CFUs across 13 strains, an order of magnitude above most Indian supplements. The Oral & Dental Care SKU pairs 2 billion CFU probiotics with five digestive enzymes, clinical in a category of flavoured dental sticks. A third product, Shroom Power, introduces a six-mushroom immunity blend.

    The depth sits in the founding team. Dr. Bacchuwar and Shrawani P., the husband-and-wife pair at the heart of the venture, operate across the US-India corridor, running the company from a base in the Pacific Northwest while building on the ground in India: clinical-grade benchmarks on one side, execution proximity on the other.

    They knew what good looked like: they had been buying it for their own Golden Doodle, Nova, “Nova was getting older, and we were on a preventive-care routine that wasn’t replicable in India for friends asking what to give their dogs,” Bacchuwar recalls. “That was the moment the gap stopped being an annoyance and became a business.”

    Joining them are Anirudha Mitkar, who built operational rigour inside Mattel’s China operations, and Manish Sevlani, a serial consumer-business entrepreneur in India. Clinical conviction at one end of the table, manufacturing discipline in the middle and India execution at the other.

    Six months in, what the company has not done is more telling. No retail-shelf land grab, no celebrity endorsement, no marketplace discounting. It has stayed on its own website, letting veterinary endorsement do the work paid acquisition usually does. In a category where supplements trade like one-off impulse buys, Whole Woofs is building the clinical layer of India’s pet care stack.

    A small-animal veterinarian in Mumbai who recommends the brand puts the gap plainly: “We have been waiting for a domestic supplement we can prescribe with the same confidence as US imports. Most of what’s on Indian shelves, I cannot in good conscience suggest for a senior dog with a real condition.”

    The under-served middle has been visible for years. What has changed is the supply side. Indian contract manufacturing has matured into nutraceutical-grade capacity that holds the GMP, HACCP, ISO 9001 tolerances clinical supplements require. The import trap was never a demand problem, it was a supply-chain one.

    No one has convincingly owned the OTC clinical supplement layer between food and pharma. Mass brands chase affordability. Vet-prescription lines build inside clinics. The OTC clinical middle is structurally underbuilt, and the brand that sets the trust baseline tends to keep it.

    Trust, in this category, is path-dependent. The first formulation a vet recommends and a pet parent re-orders becomes the default.

    The roadmap points in three directions: deeper clinical lines; partnerships with metro veterinary networks; and a measured external raise to expand manufacturing and expansion outside India.

    “We are not in a hurry to be the loudest brand in the category,” Bacchuwar says. “We would rather be the brand a vet recommends without thinking about it, five years from now.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Building for the Long Term: Nimbus Group’s Play in a Maturing NCR Market

    Building for the Long Term: Nimbus Group’s Play in a Maturing NCR Market

    By Yamini Agarwal, Director (Marketing & Communications), Nimbus Group

    New Delhi [India], May 6: Real estate, at its core, is a long-cycle business. It rewards patience, discipline, and the ability to read not just markets, but cities in transition. Over the past three decades, the National Capital Region has undergone multiple phases of urban expansion, each shaped by infrastructure, capital flows, and changing consumer aspirations.

    For Nimbus Group, the journey has been closely aligned with this evolution. What began as part of a broader financial services ecosystem gradually expanded into real estate development, with a consistent focus on execution and long-term value creation. The emphasis was never on scale for its own sake, but on building projects that respond meaningfully to the context in which they are developed.

    Delivery as a defining principle

    In a sector where credibility is often tested over time, delivery has remained the most critical differentiator.

    Nimbus Group’s early developments, including Nimbus The Arista Luxe, The Golden Palms, Express Park View, and The Hyde Park, contributed to shaping residential demand along the Noida Expressway and Greater Noida corridors at a time when these micro-markets were still emerging. These projects were not positioned as standalone offerings, but as part of a broader urban fabric, where connectivity, accessibility, and community infrastructure were becoming increasingly important.

    More importantly, they reflect a philosophy that continues to guide the group’s approach: that real estate is not simply about constructing buildings, but about enabling environments where people can live with predictability and comfort.

    This philosophy has also extended to taking on complex projects, including the completion and revival of stalled developments. In an industry recalibrating itself around accountability, such interventions are no longer optional; they are essential to restoring trust.

    Responding to a more discerning buyer

    The NCR residential market today is fundamentally different from what it was a decade ago. The shift is not just in price points, but in expectations.

    Homebuyers are increasingly evaluating projects through a multi-dimensional lens: quality of planning, density, access to open spaces, long-term maintenance, and the overall experience of living. The idea of a home has expanded beyond four walls to include the ecosystem that surrounds it.

    Nimbus Group’s current and upcoming developments reflect this shift.

    Projects such as Nimbus The Palm Village along the Yamuna Expressway are aligned with the emerging model of self-sustaining urban clusters, where residential development is supported by infrastructure, connectivity, and evolving economic activity.

    At the same time, the group’s premium offering, Nimbus The Arista Luxe, represents a more nuanced response to the growing demand for lifestyle-oriented living. Rather than viewing luxury purely through the lens of scale or specifications, such developments focus on spatial planning, design sensibility and the overall quality of the living environment.

    This transition toward more curated, lifestyle-led developments is not incidental. It is a reflection of a market that is becoming more mature and more selective.

    Aligning with the next phase of urban growth

    The emergence of new infrastructure nodes, particularly around the Noida International Airport, is likely to redefine NCR’s growth trajectory. Unlike earlier phases that were driven largely by connectivity, the current cycle is increasingly anchored in economic activity, industrial development, and employment generation.

    This has important implications for real estate.

    Markets that evolve around employment tend to demonstrate greater depth and resilience. They move beyond speculative cycles and begin to attract long-term residents, institutions and businesses.

    Nimbus Group’s expansion into these emerging corridors is therefore not just a function of land availability. It is a strategic alignment with where the next phase of urban growth is expected to unfold.

    A measured approach to growth

    As the real estate sector matures, the parameters of success are also shifting.

    Speed of launches is no longer the primary metric. Consistency of delivery, quality of execution and the ability to create enduring value are becoming far more relevant. For developers, this requires a recalibration, from volume-driven expansion to more considered, disciplined growth.

    At Nimbus, this shift is both intentional and necessary.

    The objective is not to build more, but to build better. To create developments that remain relevant not just at the point of sale, but over the lifecycle of the asset.

    Looking ahead

    The next decade of urbanisation in NCR will be shaped by a more complex interplay of infrastructure, economic activity, and consumer behaviour. It will demand greater responsibility from developers and a deeper understanding of how cities function.

    For Nimbus Group, the focus remains clear: to continue building with intent, to prioritise delivery, and to participate meaningfully in the shaping of emerging urban ecosystems.

    Real estate, ultimately, is not about projects. It is about permanence.
    And permanence can only be built on trust, discipline, and a long-term view of the city.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Steel Exchange India Secures 5-Year Renewal of Approval from MES under the Ministry of Defence

    Steel Exchange India Secures 5-Year Renewal of Approval from MES under the Ministry of Defence

    Steel Exchange India Limited (NSE: STEELXIND, BSE: 534748), one of the leading integrated steel manufacturers in South India and a trusted name in TMT rebars under the brand SIMHADRI TMT, has received renewal of approval from the Military Engineer Services (MES) under the Ministry of Defence for the supply of its TMT bars.

    The renewed approval covers TMT bars of grade Fe 500D and Fe 500D HCRM in the size range of 8 mm to 32 mm, manufactured at the Company’s integrated steel plant at Sriram Puram, Vizianagaram, Andhra Pradesh, using TEMPCORE technology.

    The approval has been renewed for a period of five years, reinforcing the Company’s continued compliance with MES’s stringent quality standards, technical evaluations, and inspection protocols.

    MES approvals are granted to a select set of manufacturers meeting rigorous criteria, creating a high entry barrier vendor base. This renewal reflects Steel Exchange India’s consistent focus on quality, process discipline, and adherence to prescribed standards over time.

    The approval remains subject to ongoing compliance requirements, including testing as per IS 1786:2008 standards and periodic inspection of manufacturing processes and quality systems by MES authorities.

    With this renewal, the Company continues to remain eligible to participate in MES projects, strengthening its presence in institutional and government-linked infrastructure segments.

    Commenting on the update, the management of Steel Exchange India Limited said: “This renewal reflects our consistent focus on quality and disciplined execution, which are critical for institutional supply. It reinforces our position in a segment characterized by stringent standards and high entry barriers. We see this as an important step in sustaining our participation in MES projects and strengthening our presence in government and infrastructure-linked segments.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Hettich Brings Its Magical Experience to Solapur with a New Hettich Exclusive (HeX) Store Launch

    Hettich Brings Its Magical Experience to Solapur with a New Hettich Exclusive (HeX) Store Launch

    Solapur (Maharashtra) [India], May 5: Hettich is strengthening its experiential footprint across the country with the continued expansion of its Hettich Exclusive store network, including the launch of its latest store in Solapur. This growing network of HeX stores is designed to bring the magic closer to the customers by offering immersive spaces to explore and engage with innovative German furniture fittings and thoughtfully designed solutions.

    The HeX Solapur store offers an integrated solution-shopping experience with curated walk-throughs of contemporary furniture fitted with advanced furniture fittings, architectural door hardware, furniture lighting and built-in kitchen appliances. Customers can also benefit from Free Design Services, where professional designers assist in visualising and planning furniture for their living spaces, making the journey from idea to execution more seamless.

    Commenting on the launch, Mr. Rahul Thakkar, Director – Sales, Hettich India, said: “Solapur is steadily evolving, with homeowners increasingly embracing modern design and premium living spaces. The demand for high-quality, functional, and well-crafted furniture with innovative fittings is clearly on the rise here. Our new HeX store brings award-winning German innovation closer to customers, offering an immersive space to explore and experience the magic of our thoughtfully designed solutions.”

    The Solapur HeX store is part of Hettich’s strategic plan to open HeX stores across India this year, strengthening its experiential ecosystem alongside Experience Centres nationwide. Each solution from Hettich is designed to be smart, durable, and tailored for evolving lifestyles. 

    Step into HeX Solapur at Mother Modular Kitchens And Interiors, Old Mahila Hospital, VIP Hotgi Road, opposite Axis Bank, Maharashtra 413003, Phone No: 7875089026

    About Hettich:

    Hettich is a 138-year-old family-owned German lifestyle brand, being one of the world’s largest manufacturers of Furniture Fittings with a global turnover exceeding 1.5 billion euros. In India, Hettich started operations at the dawn of the new millennium and within a short span of time gained an undisputed leadership position in the Indian furniture fittings industry. This year, the company celebrates 25 years of its operation in India, with the theme of ‘Built to Lead’, a powerful articulation of the journey and leadership mindset shaping its future. 

    Hettich’s product portfolio comprises a repertoire of Furniture Fittings, Architectural Hardware, Blaupunkt Built-in Appliances and Furniture Lights, providing magical interior solutions for all residential and commercial spaces.

    It is the recipient of ET Edge ‘Best Brands’ (2022 – 2025), ‘Most Preferred Brand’ 2025 and ‘Most Trusted Brands of India’ (2023 – 2027) by Marksmen Daily recognitions for its unwavering customer trust and strong brand equity. Hettich India has also been recognised among the Top 50 India’s Best Workplaces™ in Manufacturing (Large Category).

  • Fabtech Technologies Cleanrooms Limited Crosses Rs 200 Crore in Revenue, PAT Grows 18.95% in FY2026

    Fabtech Technologies Cleanrooms Limited Crosses Rs 200 Crore in Revenue, PAT Grows 18.95% in FY2026

    Mumbai (Maharashtra) [India], May 5: Consolidated Revenue up 46.9% to ₹221.72 Cr · Profit Before Tax up 17.14% to ₹19.95 Cr · PAT grows from ₹13.29 Cr to ₹15.82 Cr · Strategic synergies with Kelvin and AART deliver strong growth trends

    Overview

    Fabtech Technologies Cleanrooms Limited announced audited consolidated financial results for the year ended March 31, 2026. The Company crossed the ₹200 Crore revenue milestone, growing 46.9% year-on-year to ₹221.72 Crore. Profit Before Tax rose 17.14% to ₹19.95 Crore, and PAT attributable to shareholders grew from ₹13.29 Crore to ₹15.82 Crore.

    Management Commentary

    “FY26 was a year of deliberate investment, product, and industry expansions with reference to building. We crossed ₹200 Crore in revenue, entered new sectors, and built the foundations of an engineering ecosystem that will define Fabtech for the decade ahead. Internally, we have formulated Vision 2030 — our commitment to develop Fabtech into a powerhouse of engineering precision, with a world-class talent pool delivering exceptional project management and manufacturing outcomes for our clients, partners, and collaborators. We are building for scale, and every decision this year — from acquisitions to new industry references — was made with that horizon in mind.”

    Key Financials

    • Revenue: ₹221.72 Cr (+46.90% YoY)
    • EBITDA: ₹23.16 Cr (+28.27% YoY)
    • Profit Before Tax: ₹19.95 Cr (+17.14% YoY)
    • PAT: ₹15.82 Cr (+18.95% YoY)

    On Profitability — A Deliberate Investment & Reference Year

    PAT margins saw a compression to 7.13% (from 8.81% in FY25), and management has been transparent about the causes — all of which were planned investments, not only surprises:

    • New sector entry — Reference building: Fabtech deliberately accepted tighter margins in non-pharma sectors — including data centres, solar, and microelectronics — to establish project credentials. Winning references with marquee industry names required competitive pricing. These are now helping us build a pipeline of orders. ₹68 crore solar project for Waaree (Sangam Solar) marked a critical milestone—increasing our previous single-ticket average and establishing our footprint in high-scale renewable infrastructure.
    • Operational Integrity: Identified and neutralized internal operational leaks related to information security; the company has taken care of it due to its implementation of rigorous governance protocols and review mechanisms to protect project margins and proprietary value.
    • Supply Chain Fortitude: Unprecedented global geopolitical volatility and raw material bottlenecks that impacted the industry. The company remains confident on overcoming the situation and getting back on track.
    • Sundry debtors, amounting to ₹84 lakhs, were written off pursuant to an NCLT order. This has resulted in a decrease in profit for the year. Neutralized a ₹1 crore impact from Altair through a strategic merger into Advantek, simultaneously increasing our stake to 34.99%.
    • Sales promotion & exhibitions: Investment in sector-specific exhibitions, trade participation, and market development for new verticals/non-pharma — and tangible new project leads across data centres, solar, and semiconductors. Expanded our market presence by scaling our marketing investment to ₹3.5 crore, a 143% rise over the previous year (₹1.4 crore in FY25).
    • People & infrastructure: Employee benefit expenses nearly doubled YoY, of 103% to ₹17.7 crore (vs. ₹8.73 crore in FY25) (includes subsidiary during this year), securing the specialized expertise required for upcoming high-value projects and being future-ready. Reflecting planned headcount additions across project management and engineering, as well as enhanced employee amenities.

    Despite these investments, absolute earnings grew. PAT rose from ₹13.3 Crore to ₹15.8 Crore, representing an improvement on both topline (₹150.89 Cr → ₹221.72 Cr) and absolute earnings (₹13.29 Cr → ₹15.82 Cr) — even while bearing the full cost of sector-entry references, including solar. Margin stabilisation is management’s stated priority for FY27, and the conditions for this — normalised input costs, references converted, and a larger fixed-cost base now absorbed — are in place.

    Working Capital & Cash Flow

    Trade receivables grew from ₹53 Crore to ₹87.79 Crore — in line with revenue scaling from ₹150.89 Crore to ₹221.72 Crore. In all the companies, the last quarter saw an increase in billing, the trade receivables rose. Working capital requirements have expanded commensurately with the scale of the order book, and the Company is actively working with banking partners to enhance working capital credit limits to match the larger business it is executing. Short-term loans and advances increased accordingly as part of this structured scale-up of financing.

    Note: Geopolitical supply chain disruptions in Q4 FY2026 led to proactive inventory build-up to safeguard customer delivery timelines. While this temporarily elevated inventory and working capital outflows, it protected project execution continuity — a reflection of Fabtech’s customer-first commitment.

    Ecosystem In Action — Subsidiaries & Associates

    Fabtech’s strategy of building an integrated cleanroom ecosystem is producing measurable results. Both key subsidiaries demonstrated strong independent traction in FY2026:

    Subsidiary: Kelvin Air Conditioning & Ventilation Systems

    Fabtech increased its stake to 60.20%, consolidating Kelvin as a subsidiary. Kelvin delivered an estimated topline of ₹64.53 Crore for the year, with strong performance in both turnkey cleanroom HVAC delivery and data centre projects. Kelvin’s integration into Fabtech project bids is deepening, with procurement and margin synergies expected to reflect meaningfully in FY2027.

    Associate: Aart

    Fabtech’s stake in AART of 28% (March 2026) is showing the synergistic approach towards the microelectronics sector. AART has more than doubled its topline — from ₹16.6 Crore to ₹34.49 Crore — driven by reference project wins in non-pharma and microelectronics sectors. Margins are currently modest, consistent with a deliberate reference-building phase. This growth validates the market size and confirms AART as proof of concept for Fabtech’s sector-agnostic cleanroom strategy.

    The strategic acquisitions of Kelvin Air Conditioning & Ventilation Systems and AART have meaningfully increased consolidated topline— validating Fabtech’s ecosystem-led growth model.

    Outlook — Fy27 & Vision 2030

    • Order book: The Company maintains a strong order book, providing clear visibility into higher execution levels in FY27. Exceeding ₹199 crore (as on 31st March 2026). The ₹68 crore order under execution boosted our confidence to take on such kind of projects and are increasing our appetite.
    • New sector traction: Breakthroughs in data centres, microelectronics, and other non-pharma sectors — with notable client names. FY27 is expected to demonstrate the revenue quality of these investments.
    • Securing turnkey pharma cleanroom projects: from a panel supplier into a high-value turnkey partner by integrating Kelvin and AART, allowing us to capture the full project lifecycle with higher control and significantly higher value.
    • Margin recovery: With sector references built, input costs starting to normalise, and the fixed-cost base absorbed, management expects PAT margin stabilisation and improvement in FY27.
    • Supply side expansion: Automating manufacturing and enhancing process productivity at the Company’s Umbergaon Manufacturing Facility (UMF) in FY27, with a new Hyderabad facility commencing this year — expanding Fabtech’s ability to execute larger, more complex orders across geographies and sectors in India. Incorporated a UAE subsidiary.
    • Systems & processes: Internal processes and systems are being upgraded to improve efficiency and responsiveness to the stakeholders, especially customers, vendors, and investors. Skill-based training and HR practices have been introduced to enhance people’s productivity.
    • Growth rate: Management expects the Company to maintain growth rates (30-40%), if not improve upon them, building toward Vision 2030’s ambition of making Fabtech India’s preeminent turnkey cleanroom engineering platform.

    “We are building a sector-agnostic turnkey cleanroom capability across India. FY27 is a year of consolidation and execution — aligning our subsidiaries, our talent, and our systems into one cohesive Fabtech. We look forward to sharing much more with our partners as the year unfolds.”

    About Fabtech Technologies Cleanrooms Limited

    Fabtech Technologies Cleanrooms Limited is one of India’s leading providers of turnkey cleanroom solutions. The Company serves pharmaceutical, biotech, healthcare, data centre, solar, food processing, and is becoming sector agnostic, delivering certified controlled environments to ISO, GMP, and FDA standards.

    Disclaimer:
    This press release contains certain statements that may be deemed to be forward-looking statements and are based on management’s current expectations, including insights from audited financial information for HY & FY26. These statements are subject to various risks and uncertainties, including government actions, economic and political developments, technological changes, and other external factors that may cause actual results to differ materially.

    The Company assumes no responsibility for any decisions made based on such statements and undertakes no obligation to publicly update or revise them to reflect subsequent events or circumstances. For detailed financial information, please refer to official filings submitted to the stock exchanges.

  • KRM Ayurveda Limited Crosses JPY 100+ Crore Revenue Milestone in FY26;H2 FY26 EBITDA Grows ~100% YoY and PAT Surges ~149%, with PAT MarginsNearly Doubling

    KRM Ayurveda Limited Crosses JPY 100+ Crore Revenue Milestone in FY26;H2 FY26 EBITDA Grows ~100% YoY and PAT Surges ~149%, with PAT MarginsNearly Doubling

    New Delhi [India], May 5: KRM Ayurveda Limited (NSE: KRMAYURVED), one of India’s emerging integrated Ayurvedic healthcare platforms, announced its audited financial results for the year ended March 31, 2026.

    Financial Performance Highlights

    H2 FY26 vs H2 FY25

    Particulars (₹ In Lakhs) H2 FY26 H2 FY25 YoY Growth
    Revenue from operations 5,333.36 4,084.19 30.59%
    EBITDA 1,787.10 884.09 102.14%
    EBITDA Margin (%) 33.51% 21.65% 1,186.00 BPS
    PAT 1,189.73 478.12 148.84%
    PAT Margin (%) 22.31% 11.71% 1,060.00 BPS

    FY26 vs FY25

    Particulars (₹ In Lakhs) FY26 FY25 YoY Growth
    Revenue from operations 10,169.07 7,655.27 32.84%
    EBITDA 3,112.02 1,914.02 62.59%
    EBITDA Margin (%) 30.60% 25.00% 560.02 BPS
    PAT 2,012.00 1,121.41 79.42%
    PAT Margin (%) 19.79% 14.65% 513.66 BPS

    Key Business Highlights

    • Diversified Revenue Mix Driving Stability: KRM’s business model has evolved from being predominantly product-led in FY23, with services contributing just 6.59% of total sales, to a more balanced integrated healthcare model, with services contributing rising to 63.21% in FY26.
    • Expanding Integrated Healthcare Footprint: KRM now operates 6 hospitals, 8 clinics, 223+ bed capacity, with 40 physicians and 71 therapists across India.
    • IPO-Led Capital Strengthening: Following its ₹ 77 Crore NSE Emerge IPO, KRM strengthened liquidity & positioned itself for telemedicine, expansion, and medical tourism.

    Industry Opportunity

    • India’s AYUSH market, valued at ~$43 billion in 2024, is projected to reach ~$200 billion by 2030, driven by preventive healthcare, digital health, wellness tourism, and government support.

    Growth Drivers

    • Telemedicine scale-up
    • Tier II/III hospital expansion
    • International teleconsultation
    • Medical tourism
    • Certified Ayurveda training programs
    • Expanded product portfolio
    • Wider OTC distribution

    Speaking on the Company’s Financial and Strategic Performance, Dr. Puneet Dhawan, Managing Director & Promoter, said:

    “Our FY26 performance marks a transformational year for KRM Ayurveda as we crossed the %100 crore revenue milestone in FY26, while H2 FY26 EBITDA surged ~102% YoY and PAT grew ~149% YoY, reflecting the strength of our integrated healthcare model and disciplined execution. Our strategic focus on expanding hospitals, specialty care, and digital health is driving stronger margins, improving revenue quality, and deepening consumer trust. Backed by a strengthened post-IPO balance sheet, we are well-positioned to accelerate growth across India and global markets through digital healthcare, medical tourism, and innovation-led Ayurveda solutions.”

    About KRM Ayurveda Limited

    KRM Ayurveda Limited, established in 2019, is an integrated Ayurvedic healthcare company combining hospitals, clinics, telemedicine, product manufacturing, and D2C wellness solutions. Originally founded as a kidney-specialty hospital, it has evolved into a multispecialty platform offering holistic healthcare through authentic Ayurveda, modern practices, and scalable digital health solutions.

    Website: www.akmiladvisors.com

    Disclaimer: Certain statements in this document that are not historical facts are forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including government actions, local, political, or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.